Hospice is a successful model for providing palliative care and psychosocial support to terminally ill patients. Although most patients who receive hospice care have cancer, patients with acquired immunodeficiency syndrome increasingly are taking advantage of these programs. Since 1983, Medicare has provided hospice reimbursement for patients meeting four criteria: (1) life expectancy of six months or less as certified by a physician; (2) unable to benefit from aggressive or curative therapy; (3) able to receive at least 80% of care at home; and (4) availability of an individual who can provide custodial care and serves as a "proxy" decision maker for health care decisions if the patient becomes mentally incapacitated.1
See also p 2540.
Unfortunately, predictions regarding life expectancy are often imprecise, a problem in determining eligibility for hospice care. In this issue of the Archives, Forster and Lynn2 present further evidence of this lack of accurate prognostication
Pearlman RA. Inaccurate Predictions of Life Expectancy: Dilemmas and Opportunities. Arch Intern Med. 1988;148(12):2538. doi:10.1001/archinte.1988.00380120007001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: